Patents/Assignees

NURIX THERAPEUTICS, Inc.

13 patents in portfolio

US12600732utility2026
Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
0 cites
US12594263utility2026
CBL Inhibitors and Compositions for Expansion of Immune Cells
0 cites
US12582722utility2026
Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
0 cites
US12583862utility2026
Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
0 cites
US12485144utility2025
3-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
0 cites
US12377106utility2025
Piperidinylpyrazine-carboxamide Compounds for Treating and Preventing Cancer and for Degrading BTK
0 cites
US12234230utility2025
Substituted Benzyl-triazole Compounds for Cbl-b Inhibition, and Further Uses Thereof
0 cites
US12121540utility2024
CBL Inhibitors and Compositions for Use in Adoptive Cell Therapy
0 cites
US12049471utility2024
Cyano Cyclobutyl Compounds for Cbl-b Inhibition and Uses Thereof
0 cites
US12016860utility2024
Combination Therapies with Cbl-b Inhibitor Compounds
0 cites
US11951133utility2024
3-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
0 cites
US11866442utility2024
Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
0 cites
US11820781utility2023
Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
0 cites